Related Experiment Video
Updated: Sep 3, 2025

03:51
Author Spotlight: Investigating Wound Healing in Mice Models of Oronasal Fistulas
Published on: September 8, 2023
1.2K
Development of an In Vivo Model for Eustachian Tube Dysfunction
Niels Oppel1, Malena Ezzat1, Philipp Krüger2
1Department of Otorhinolaryngology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
Bioengineering (Basel, Switzerland)
|July 25, 2022
Summary
Researchers developed a novel large animal model for Eustachian tube dysfunction (ETD) by injecting hyaluronic acid (HA) fillers. This reproducible method allows testing new treatments like Eustachian tube (ET) stents.
Area of Science:
- Otolaryngology
- Medical Engineering
- Animal Models
Background:
- Otitis media frequently correlates with Eustachian tube dysfunction (ETD).
- A significant gap existed in large animal models for evaluating novel Eustachian tube (ET) treatments, such as stenting.
Purpose of the Study:
- To establish a reproducible large animal model for inducing ETD without permanent Eustachian tube (ET) closure.
- To develop and validate a method for testing new therapeutic interventions for ETD.
Main Methods:
- Development of specialized tools for safe hyaluronic acid (HA) injection near the Eustachian tube (ET) in blackface sheep.
- Utilizing cone beam computed tomography (CBCT) and magnetic resonance imaging (MRI) for visualizing HA depots and guiding stent placement.
- In vivo validation through tympanometry to assess middle ear ventilation and induction of ETD.
Main Results:
- Successful induction of ETD in sheep using 2.5 mL or higher of HA, with no observed complications or animal distress.
- The induced ETD persisted for 3 to 13 weeks and was associated with middle ear effusion.
- Demonstrated feasibility of stent placement within the ET following HA injection.
Conclusions:
- A reliable and reproducible large animal model for Eustachian tube dysfunction (ETD) has been successfully established.
- This model provides a platform for preclinical evaluation of innovative treatments, including Eustachian tube (ET) stents.
- The HA injection technique offers a temporary and controllable method for studying ETD and its management.

